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ABSTRACT
Objectives Rheumatoid arthritis (RA) is characterised
by breach of self-tolerance towards citrullinated antigens
with generation of anti-citrullinated peptide/proteins
antibodies (ACPA). Currently, the nature and source of
citrullinated antigens driving the humoral autoimmune
response within synovial ectopic lymphoid structures
(ELS) is a crucial unknown aspect of RA pathogenesis.
Here we characterised the autoreactive B-cell response of
lesional B cells isolated from ELS+RA synovium.
Methods Single synovial tissue CD19+cells were
Fluorescence Activated Cell Sorting (FACS)-sorted and
VH/VL Ig genes cloned to generate recombinant
monoclonal antibodies (rmAbs) from patients with ELS
+/ACPA+RA.
Results RA-rmAbs immunoreactivity analysis provided
the following key findings: (1) in a chIP-based array
containing 300 autoantigens and in a ‘citrullinome’
multiplex assay, a strong reactivity against citrullinated
histones H2A/H2B (citH2A/H2B) was observed in ∼40%
of RA-rmAbs, followed by cit-fibrinogen and cit-vimentin;
(2) anti-citH2A/H2B-reactive RA-rmAbs (but not anti-
citH2A/H2B negative) selectively recognised neutrophil
extracellular traps (NETs) from peripheral blood and/or
RA joint neutrophils; (3) anti-citH2A/citH2B and anti-NET
immunobinding was dependent on affinity maturation
and was completely abrogated following reversion of
hypermutated IgVH/VL genes to germline sequences; (4)
ELS+ (not ELS−) RA synovial tissues engrafted into
Severe Combined ImmunoDeficiency (SCID) mice released
human anti-citH2A/citH2B and anti-NET antibodies in
association with the intra-graft expression of CXCL13
and lymphotoxin (LT)-β, two master regulators of ELS.
Conclusion We provided novel evidence that B cells
differentiated within synovial ELS in the RA joints
frequent target deiminated proteins which could be
generated during NETosis of RA synovial neutrophils
including histones. Thus, NETs could represent a source
of citrullinated antigens fuelling the ACPA autoimmune
response within the RA synovium.
INTRODUCTION
Rheumatoid arthritis (RA) is characterised by
breach of self-tolerance towards citrullinated pro-
teins (anti-citrullinated peptide/proteins antibodies
(ACPA)), which can occur years prior to clinical
onset of RA at extra-articular sites.1–6 Several post-
translationally deiminated proteins have been
indicated as a potential source of citrullinated anti-
gens in the RA joints,3 but to date their cellular
source and specific contribution to the lesional
ACPA response is unknown.
Around 40%–50% of patients with RA display syn-
ovial ectopic lymphoid structures (ELS) characterised
by B-cell follicles supporting a germinal centre (GC)
response.7 8 Synovial ELS are self-sustained niches
whereby autoreactive B cells undergo antigen-driven
selection/differentiation with local antibody diversifi-
cation through Ig genes somatic hypermutation
(SHM)9 and class switching.10
Citrullination, or arginine deimination, is cata-
lysed by the enzyme peptidyl-arginine-deiminase
(PAD). In the RA synovium, monocyte–macro-
phages are the main source of this enzyme.11 12 As
a result, citrullination of fibrinogen, vimentin and
α-enolase, among others, has been observed within
the RA joints and associated with circulating
ACPA.13–15 Accordingly, monoclonal antibodies
generated from synovial fluid B cells frequently
react against citrullinated antigens.16
PAD-mediated deimination of core histones
(H2A/H2B/H3/H4) has been described in neutro-
phils during the neutrophil extracellular traps
(NETs) formation, or NETosis, a form of cell death
which enhances the antimicrobial properties of acti-
vated neutrophils.17 18 Interestingly, RA synovial
fluid neutrophils display an enhanced NETosis in
the absence of microbial stimuli due to the RA
proinflammatory milieu19 and RA sera react against
citrullinated H4 from NETs.2
At present, direct evidence that synovial B cells
from ELS+RA recognise citrullinated proteins and
the specific contribution of different citrullinated
antigens in fuelling the lesional ACPA production
is missing. To this aim, we investigated the
immunoreactivity of recombinant monoclonal
antibodies (rmAbs) generated from single
synovial B-cell clones obtained from patients with
ELS+/ACPA+RA.
MATERIALS AND METHODS
A full list of methods is reported in the online sup-
plementary methods.
Patients
Three synovial tissues from total joint
replacement were obtained after informed consent
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(National-Research-Ethics-Service–Committee-London-LREC05/
Q0703/198) from patients with ACPA+ RA (all females, age
range 66–75, all on combination Disease-Modifying
AntiRheumatic Drug (DMARD) therapy including methotrex-
ate) diagnosed according to the revised American College of
Rheumatology (ACR) criteria.20 This board specifically
approved the collection of the synovial tissue. Synovial tissue
was dissected and processed as previously described.10
Synovial mononuclear cell isolation and CD19+ cell FACS
sorting
Mononuclear cells were isolated from fresh synovial tissue speci-
mens obtained as above. Detailed method is reported in the
online supplementary methods.
Generation of recombinant monoclonal antibodies
Single-cell real time-PCR reactions and IgV gene amplification
were performed as described in refs. 21 and 22. Briefly, cDNA
from CD3-CD19+B cells was amplified using reverse primers
that bind the Cμ/Cγ or Cα constant region in three independent
nested-PCR. The complete sequence of primers is reported in
online supplementary table S1. Aliquots of Variable Heavy (VH)/
Vκ/Vλ chains second PCR products were sequenced with the
respective reverse primer and analysed by IgBlast. IgH comple-
mentary determining region (CDR)3 amino acids and length
were determined as described.21 The V gene somatic mutations
analysis was performed using IMmunoGeneTics/Variable (IMGT/
V)-QUEry and STandardization (QUEST) to characterise the
silent versus non-silent mutation in each Framework Region (FR)/
CDR region to determine the R:S ratio. The expression vector
cloning strategy and the monoclonal antibody production were
performed as described in ref. 21. Immunoglobulin Analysis Tool
(IgAT) software was used to calculate the probability of antigen-
driven selection within the Ig repertoire of the RA-rmAbs,23 as
previously described.22
Multiplex autoantibody assay
The multiplex autoantibodies assay containing 20 citrullinated
RA-associated antigens (see online supplementary table S2) was
performed as previously published.5 Briefly, rmAbs were added
at 10 μg/mL to custom Bio-Plex beads associated with RA puta-
tive autoantigens and incubated at room temperature (RT) for
1 h. After washing, PhycoErythrin (PE)-anti-human-IgG anti-
body was added to the beads and incubated at RT. The fluores-
cence of PE detected (Luminex200,Bio-Plex-Software V.5.0,
Bio-Rad) reflects the amount of antibodies that bind to the
beads.
ELISA assay for anti-citrullinated H2A and H2B
ELISA plates were coated with citrullinated or unmodified his-
tones H2A or H2B at 10 μg/mL in Phosphate Buffered Saline
(PBS). Samples at 10 μg/mL were transferred into the ELISA plate
and incubated for 2 h (SCID serum diluted 1:10). Unbound anti-
bodies were removed by washing before incubation for 1 h with
horseradish peroxidase coupled goat-anti-human-IgG. Assays
were developed using TetraMethylBenzidine (TMB) Substrate
Reagent Set (Becton Dickinson Optical Enzyme ImunoAssay
(BDOptEIA)). Optical densities (ODs) were measured at 450 nm.
Stimulation of NETosis and immunofluorescence microscopy
on NETs
Neutrophils were isolated from peripheral blood (PB) of healthy
donors or synovial fluid of two patients with RA using discon-
tinuous gradient centrifugation according to ref. 24 and seeded
onto cell culture cover slides at 2×105 cells/well. Cells were
either fixed with 4% paraformaldehyde or before fixation acti-
vated with 100 nM Phorbol Myristate Acetate (PMA) for 4 h at
37°C. NETs were stained with RA-rmAbs or Sjögren’s syndrome
(SS) control rmAbs diluted in PBS for 1 h (RT). After washing
with Tris Buffered Saline (TBS), Alexa488-goat-anti-human-IgG
(Invitrogen, 1:200) was added for 30 min (RT). 4’, 6-
DiAmidino-2-PhenylIndole (DAPI) (Invitrogen) was added to
visualise the NETs. All sections were visualised using an
Olympus BX60 microscope. All rmAbs have been tested at
10 μg/mL.
RA synovial tissue transplantation into SCID mice
RA SCID chimaeras were established as previously described.10
Sera and synovial grafts were harvested and analysed for auto-
antibodies and gene expression profiling, respectively, as previ-
ously reported.10 Detailed method is reported in the online
supplementary methods.
Statistical analysis
Differences in quantitative variables were analysed by the
Mann–Whitney U test (two groups) and by the Kruskal–Wallis
with Dunn’s post-test (multiple groups). χ2 test with Yates’s cor-
rection or Fisher’s exact test when required were used to evalu-
ate associations of qualitative variables in the different groups.
All the statistical analyses were performed using
GraphPad-Prism5.01. A p value <0.05 was considered statistic-
ally significant. For array reactivity, the Significance Analysis of
Microarrays algorithm to normalise array median fluorescence
intensity values was applied.
RESULTS
Ig gene analysis demonstrates intra-synovial antigen-driven
B-cell affinity maturation and clonal diversification in ELS
+RA synovium
We sorted single CD19+B cells from synovial cell suspension
obtained from three joint replacements of patients with ELS
+/ACPA+RA (figure 1A, B). Sequence analysis of different VH/
JH regions (n=139) and VL regions (Vk=94;Vl=81) demon-
strated that the VH/VL gene repertoire of the synovial B cells was
similar to PB CD5-IgM+B cells of healthy donors9 25 (figure
1E–G). We observed statistically different JH gene usage with
JH2/JH3 and JH5 over-represented in the IgM and IgG synovial
B cells, respectively, and JH4 less frequent in the IgG compart-
ment (figure 1E). Generally, we observed a similar frequency in
the distribution of IgM (33%), IgG (40%) and IgA (27%) iso-
types across all sequences analysed (figure 1C, D). IgG and IgA
synovial B-cell clones showed significantly higher number of
SHM in their VH region compared with IgM, ∼50% of which
displayed germline sequences (see figure 2A and online supple-
mentary figure S1A); additionally, SHM in Variable Light (VL)
was higher in κ than λ chains (figure 2B). Switched B-cell clones
also showed (1) high ratios of replacement (R) to silent (S)
mutations in CDR1-2 compared with the FR1-3 regions (see
figure 2C and online supplementary figure S1B), (2) a shorter
CDR3 length compared with unswitched unmutated IgM
+clones (figure 2D) and (3) a higher frequency of positively
charged aa, which have been shown to be frequently used by
autoreactive B cells26 (figure 2E). We estimated that between
24% and 30% of the sequences (probability 0.05 and 0.1,
respectively) from the synovial B cells display evidence of
antigen selection (see online supplementary figure S2). Full anti-
bodies characteristics are provided in online supplementary table
S4. Clonal relationship analysis of the VH gene sequences of RA
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synovial B cells showed evidence of intra-synovial diversification,
as previously reported9 (figure 2f).
RA synovial rmAbs display frequent immunoreactivity
towards citrullinated histones
To investigate the autoantigenic immunoreactivity of the syn-
ovial B-cell clones, we cloned matching VH+VL Ig genes from
individual B cells into specific expression vectors and produced
66 in vitro whole rmAbs as complete IgG1 displaying identical
VH+VL pairing and specificity of the parental B cells.
21 26
Sufficient yield (>5 μg/mL) was obtained from 59 rmAbs
(RA015/11=12; RA056/11=26; RA057/11=21), which were
used for downstream analysis. First, we screened the RA-rmAbs
in a synovial autoantigen microarray platform27 and in a multi-
plex RA-associated citrullinated antigen assay.5 Strikingly,
RA-rmAbs (∼40%) showed strong immunoreactivity towards
citrullinated histones H2A (citH2A) and citH2B by multiplex
assay (figure 3A) with reactivity to histones H2A and H2B also
frequently observed in the protein array heatmap (see online
supplementary figure S3). Quantitative analysis confirmed that
the strongest reactivity was directed against citH2A and citH2B
followed by citrullinated vimentin and fibrinogen (figure 3B).
Additionally, 5 rmAbs displayed binding to different citrullinated
antigens, highlighting the existence of clones with multiple
citrullinated reactivity. In particular, reactivity to citrullinated
vimentin was demonstrated by ELISA in three RA-rmAbs (see
online supplementary figure S4).
Overall, 41% (24/59) and 34% (20/59) of the RA-rmAbs were
above the threshold of citH2A and citH2B reactivity, respectively
(figure 3C). Such reactivity was confirmed to be disease-specific
as it was not detectable in 30 control rmAbs from circulating
naïve and memory B-cells of five patients with ANA+/ENA+ SS
(see online supplementary figure S5). To confirm the importance
of citrullination, we tested the RA-rmAbs towards the native
versus citrullinated form of H2A and H2B by ELISA. A signifi-
cant increase was detected in the binding to citH2A/H2B com-
pared with native H2A/H2B histones in a large proportion of
rmAbs from ELS+ACPA+RA synovial B cells but not in either
Figure 1 Histological characterisation of synovial ectopic lymphoid structures (ELS), single synovial CD19+ cell sorting and VH/VL Ig gene analysis.
(A) Representative immunohistological characterisation of synovial tissue samples from patients with rheumatoid arthritis (RA) used in this study
(RA015/11, RA056/11 and RA057/11). To assess the presence of ELS, sequential paraffin tissue sections were stained for CD20 (B cells, left-panel),
CD3 (T cells, central-panel) and CD138 (plasma cells, right-panel), respectively. (B) Isolation strategy of single CD19+ RA synovial B cells is shown.
Mononuclear cells were surface labelled with fluorochrome-coupled anti-CD19 and anti-CD3 antibodies; the sorting gate strategy for single CD19
+CD3− B cell is shown. A total of 50 000 events is shown in the FACS plot. (C) The frequencies of μ, γ and α heavy chain among all CD19+ B cells
for which VH sequences were obtained are shown. (D) Frequencies of μ, γ and α heavy chain among all CD19+ B cells for each synovial tissue are
shown. (E) The VH and JH gene repertoire of single CD19+ synovial B cells for each individual chain isotype, μ (white), α (grey) and γ (black) is
shown. (F) The Vκ and (G) Vλ gene repertoire are shown. The red bars indicate the V(H+L) gene repertoire of peripheral blood-naïve B cells. The
absolute number of sequences analysed is reported over each graph. Error bars in bar graph indicate SEM for individual patients. p Values compare
data from RA synovial B cells with peripheral blood-naïve B cells; *p<0.05; ***p<0.001.
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naïve or memory SS B cells or flu control rmAb (figure 3D, E).
Interestingly, using as substrate synthetic citrullinated H2A pep-
tides spanning the whole histone H2A length, we showed that
different antibodies each recognised different citrullinated H2A
epitopes (figure 3F), suggesting the occurrence of in situ ‘epitope
spreading’. The immunoreactivity observed against citrullinated
Figure 2 VH/VL Ig gene analysis demonstrating intra-synovial antigen-driven B-cell affinity maturation and clonal diversification. Ig gene
sequences of CD19+ synovial B cells were analysed for the absolute numbers of somatic mutations in VH genes (FRs+CDRs) (shown separately for
IgM, IgG and IgA clones in (A) as well as VL genes (κ and λ shown separately in (B)). (C) Frequency of replacement (R) and silent (S) mutation ratio
in FR (white) and CDR (black) regions for IgM, IgG and IgA is shown. Significant differences between the R/S ratio in FR versus CDR regions of IgG
and IgA clones are shown: (D) IgH CDR3 aa length and (E) number of positively charged aa in the CDR3 is shown for each heavy chain isotype
separately. (F) Lineage trees generated by comparison of Ig VH sequences of synovial B cells are shown. Clonally related B cells were identified
based on cells derived from a single germline rearrangement characterised by the same V, D and J gene usage, CDR3 length and sequence.
The synovial B-cell clones are depicted as white circle, the putative common progenitor as grey circle and the germline sequences as black
circle. The number inside the circle corresponds to the name of the clone and the number beside the line represents the additional mutation
acquired. At the bottom of each clone the correspondent Ig VL sequence is indicated; na=not available and it indicates those genes for the light
chain only that could not be amplified; *p<0.05 and **p<0.01.
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histones or multiple citrullinated antigens was not due to poly-
reactivity, a phenomenon frequently observed in rmAbs gener-
ated from naïve B cells28 as only 1/59 clones displayed
polyreactivity against multiple structurally unrelated antigens21 26
(see online supplementary figure S6).
RA synovial rmAbs with cit-histones specificity bind
neutrophils NETs
We next investigated the biological significant of the observed
immunoreactivity towards citrullinated histones. First, we
showed that the RA SF-neutrophils spontaneously undergo
NETosis, as previously described19 (figure 4D, top). We assessed
whether synovial RA-rmAbs reactive against citrullinated his-
tones could specifically target NETs. A large proportion of
RA-rmAbs displayed strong binding to NETs generated from
either PB-neutrophils of healthy donors (figure 4A) or from
RA SF-neutrophils (figure 4D) with 33%, 42% and 19% of
the total synovial antibody response of patients RA015/11,
RA056/11 and RA057/11, directed against NETs, respectively
(figure 4E). Conversely, none of the control SS-rmAbs displayed
anti-NET reactivity (figure 4B–D). Of relevance, the immunor-
eactivity of the RA-rmAbs was restricted to neutrophils undergo-
ing NETosis with negligible or no binding to the nucleus of
resting neutrophils.
Of relevance, the reactivity towards NETs was strongly asso-
ciated with the level of immunobinding to citrullinated histones
in the multiplex assay (see multiplex tiles in figure 4C) and in
ELISA (figure 4F).
Synovial B cells anti-NET immunoreactivity is dependent on
SHM and is lost after reversion to germline
A progressive increase in the mutational load within the VH Ig
genes was associated with higher reactivity to citrullinated his-
tones in all the isotypes obtained, with the strongest difference
observed in IgG-switched B-cell clones (figure 5A). Therefore,
to address the importance of affinity maturation and clonal
Figure 3 Characterisation of the binding of the rheumatoid arthritis (RA) synovial recombinant monoclonal antibodies (rmAbs) towards
citrullinated antigens demonstrates biased immunoreactivity towards citrullinated histones. (A) Luminex heatmap is shown. Heatmap tiles reflect the
amount of IgG autoantibody binding reactivity based on the fluorescence intensity scale as indicated on the top-right. rmAb-IDs (individual columns,
top labelling) and the location of each citrullinated antigen in the assay (individual rows, right side legend) are shown. (B) Column bar graph
representation of the mean fluorescence intensity (FI+SEM) of the luminex heatmap for each citrullinated antigen. (C) Pie charts showing the general
percentage of reactivity towards citH2A (top) and citH2B (bottom) histones of the RA-rmAbs after correction of background signal and breakdown of
the prevalence in each individual synovial tissue. (D and E) Binding of the RA and control rmAbs (30 naïve/memory B-cell clones from patients with
Sjögren’s syndrome (SS)) to native and in vitro citrullinated histone H2A and H2B tested by ELISA. Results are grouped according to tissue donors
and shown as increased percentage of binding comparing native versus citrullinated histones. A flu control rmAb is shown in red. The dotted
horizontal line represents the cut-off for positivity of the rmAbs which was determined as the mean+2SD of the 30 SS rmAbs reactivity (right panel).
(F) Binding of the RA-rmAbs (black circles=non-reactive; coloured circles=reactive) and control rmAbs (open circles) to citrullinated histone H2A
peptides tested by ELISA (H2A1-21Cit; H2A27-47Cit; H2A69-90Cit; H2A79-98Cit; H2A94-113Cit) is shown. Results are expressed as absorbance at
405 nm. Each coloured circle represents an individual RA-rmAb.
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diversification via SHM in the anti-NET reactivity, we reverted
selected highly mutated RA-rmAbs with strong NETs reactivity
to the corresponding VH+VL Ig germline sequences by
overlapping PCR. The germline RA-rmAbs invariably lost their
reactivity towards NETs (figure 5B). These data demonstrate
that intra-synovial antigen-driven SHM is required for the
immunoreactivity of RA synovial B-cell clones to
NET-associated autoantigens.
ELS+RA synovia sustain anti-NET and anti-citrullinated
histone antibodies in vivo in the Hu-RA/SCID chimeric
mouse model
Finally, we investigated whether the anti-NET and anti-citH2A/
H2B reactivity of the RA-rmAbs were reproduced in whole RA
synovial tissue obtained from the same joints. For this purpose we
used an in vivo chimeric human RA/SCID mouse transplantation
model (figure 6A). As we had previously shown,10 RA synovial
ELS were self-maintained for several weeks in the absence of recir-
culating immune cells (figure 6B) and released IgG-ACPA autoanti-
bodies (measured as total anti-CCP-IgG, not shown). Mouse sera
from mice transplanted with RA015/11 or RA056/11 synovial
grafts contained autoreactive human anti-NET IgG (figure 6C)
and/or anti-citH2A/citH2B histones antibodies (figure 6D).
Additionally, in the synovial grafts of mice producing
anti-citrullinated histones/NETs we observed significantly higher
levels of CXCL13, CXCR5 and lymphotoxin (LT)β mRNA, which
are master regulators of ectopic lymphoid neogenesis29 and are
selectively upregulated in ELS+RA synovium10 30 (figure 6E).
Figure 4 Rheumatoid arthritis (RA) synovial recombinant monoclonal antibodies (rmAbs) display selective immunoreactivity towards neutrophil
extracellular traps (NETs). Representative pictures of PMA-stimulated neutrophils incubated with RA synovial (A) versus control Sjögren’s syndrome
(SS) rmAbs (B), demonstrating selective immunoreactivity of RA-rmAbs towards NETs. NETs are clearly evident as web-like structures rich in nuclear
material stained by DAPI (blue, left columns) and are strongly bound by RA synovial (but not SS) rmAbs (green, middle columns, with overlap
staining in the right columns). Corresponding multiplex tiles reporting the binding of the same rmAb towards citH2A and citH2B histones are
reported beside each ImmunoFluorescence (IF) staining (C), demonstrating good accordance with anti-NET staining. (D) Binding of the RA synovial
rmAbs to NETs is confirmed also in using synovial fluid neutrophils. Top image: RA SF-neutrophils seeded untreated onto cell culture cover slides for
30 min before fixation with 4% ParaFormAldehyde (PFA). A representative picture is shown. (E) Pie chart displaying the percentage of synovial
rmAbs reacting towards NETs within individual synovial tissue demonstrated that up to 42% of the intra-synovial humoral response is directed
towards NETs. (F) Subanalysis of the ELISA immunoreactivity towards citH2A and citH2B histones demonstrates significantly higher binding in
anti-NET+ versus anti-NET− clones.
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DISCUSSION
A common feature of RA is the formation of discrete clusters of
infiltrating lymphomononuclear cells forming lymphoid aggre-
gates or ELS.7 8 10 These structures resembling secondary lymph-
oid organs sustain a functional ectopic-GC response and support
B-cell differentiation into high affinity autoantibody-producing
cells.29 31 ELS formation is dependent on the activation of the
LT-β/lymphoid chemokines pathway in ectopic sites32 and is
driven by chronic antigenic stimulation.31 As such, ELS (also
observed in non-autoimmune conditions such as chronic infec-
tions, allograft rejections and cancer31) are unique in their ability
to mount disease-specific and antigen-specific immune responses.
Indeed, ectopic-GCs produce antibodies against citrullinated pro-
teins in RA,10 33 34 ribonucleoproteins Ro/La in SS,35 36 thyro-
globulin and thyroperoxidase in Hashimoto’s thyroiditis37 and
acetylcholine receptor in myasthenia gravis.38
Here, we exploited these unique features of ectopic-GC to
unravel the nature and source of the citrullinated antigens
driving adaptive immune responses in the RA joints generating
full rmAbs from the joints of patients with ACPA+RA containing
functional ectopic-GCs. As control, due to the absence of a direct
comparator as ELS synovitis do not harbour B cells for cloning,10
we used rmAbs generated from circulating naïve and
Ag-experienced memory B cells of patients with SS to exclude
that any observed reactivity was due to non-specific autoimmun-
ity, as circulating SS B cells are frequently autoreactive.22
The rmAbs generated in this study have identical specificity of
the parental B cells providing us the advantage of combining Ig
gene repertoire and B-cell clonal analysis together with the char-
acterisation of humoral immunoreactivity at clonal level.26 We
adopted an unbiased approach sorting single CD19+ synovial
tissue cells to have a true representation of the frequency and
specificity of the autoimmune response against citrullinated anti-
gens. Previous work generated rmAbs from RA synovial fluid
IgG+ B cells and showed frequent reactivity to selected citrulli-
nated antigens.16 Of relevance, synovial fluid rmAbs are not
clonally related; conversely, the B-cell clones that we isolated
displayed highly somatically hypermutated IgVH+VL genes with
evidence of intra-synovial clonal diversification compatible with
their antigen-driven selection in ectopic-GC, similar to previous
studies which microdissected ectopic-GC.9 This was particularly
evident for IgG+ and IgA+ clones, while around 50% of the
IgM+ B cells displayed germline sequences. As recently
reported,39 we observed a high prevalence of IgA+ B cells in
the RA joints in line with previous evidence that FDC-like syn-
ovial stromal cells directly induce IgA class-switch via a B cell
Activating Factor of the TNF Family (BAFF) and A
PRoliferation Inducing Ligand (APRIL)-dependent pathway.40 41
Importantly, we demonstrated that around 40% of RA
synovial B cells from ectopic-GCs displayed reactivity against
citrullinated antigens. Although, we observed frequent cross-
citrullinated reactivity, using a multiplex ‘citrullinome’ assay, we
showed that the strongest reactivity of ACPA-producing B cells
was directed towards citrullinated histones, mainly H2A and
H2B, followed by cit-vimentin and cit-fibrinogen. The data on
histone reactivity were further confirmed (1) in vitro using
several immunoenzymatic methods and cell-based NETs
co-localisation experiments and (2) in vivo by engrafting ELS+
synovial tissues into SCID mice where we showed that the syn-
ovial production of anti-citH2A/citH2B and anti-NET autoanti-
bodies is critically dependent on ELS formation and is sustained
by high levels of CXCL13 and LTβ. Although our work clearly
Figure 5 Immunoreactivity towards neutrophil extracellular traps (NETs) is dependent on somatic hypermutation. (A) Subanalysis of the
anti-citH2A (top) and citH2B (bottom) histone reactivity in ELISA according to the number of somatic mutations in the VH regions of IgM (left), IgG
(central) and IgA (right) clones demonstrates progressive increase in immunoreactivity according to the mutational load in all isotypes. (B) Reversal
to germline (GL) sequences by overlapping PCR in representative individual anti-NET+ rheumatoid arthritis (RA) recombinant monoclonal antibody
(rmAb) invariably abrogated the binding to NETs. The family usage, CDR3 sequence and the total number of somatic mutations in the FR and CDR
regions of VH and VL Ig genes prior to reversal to GL sequences is shown beside each IF staining; *p<0.05; **p<0.01.
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suggest that cit-histones are critically targeted by synovial-
derived ACPA, further work dissecting the fine specificities of
the rmAbs towards multiple citrullinated antigens is warranted,
also considering that the binding of ACPA can be greatly influ-
enced by immunodominant epitope density and citrullination
protocols in different assays.
Histone citrullination is a critical step in the formation of
NETs released from neutrophils in response to infectious or
inflammatory stimuli to trap and kill pathogens.19
Approximately 70% of all NETs proteins are histones in which
arginine residues are deiminated to citrulline. Thus, NETosis
allows the extracellular exposure of heavily citrullinated histones
and, to a much lesser degree, also of other putative RA autoanti-
gens such as citrullinated vimentin19 which can become the
target of the autoimmune ACPA response. Interestingly, the
reactivity towards citrullinated vimentin, which was relatively
low in our antibodies, was recently described in work using
rmAbs derived from synovial fluid B cells, which however did
not investigate the reactivity towards citrullinated histones and
NETs.16
The RA-rmAbs reactive towards citH2A/H2B also strongly
and specifically recognised NETs in cell-based immunoassays
using either RA-synovial fluid or circulating activated neutro-
phils as substrate. These data are highly relevant to RA patho-
physiology since recent observations showed that (1)
RA-synovial fluid neutrophils undergo aberrant NETosis and
release citrullinated antigens19 and (2) patients with ACPA+RA
sera recognise citrullinated histones from NETs.2
Importantly, the RA-rmAbs anti-NET immunoreactivity was
entirely dependent on SHM in the IgVH genes since it was
completely abrogated when the IgVH+VL genes were reverted
into germline sequences. These data demonstrate that the
anti-cit-histones/NET immunoreactivity is largely acquired
within the synovial microenvironment on affinity maturation
and intra-synovial diversification within ectopic-GC. Because
these processes in B cells are largely dependent on cognate T-cell
help, it is conceivable that Th cells with TCRs specific for pro-
cessed NET peptides may be present in the RA synovium and
engaged by antigen-presenting cells loading citrullinated NETs
antigens. In this regard, recent evidence suggests that some NET
Figure 6 Ectopic lymphoid structures (ELS)+ rheumatoid arthritis (RA) synovia are self-maintained and release anti-neutrophil extracellular traps
(NETs) and anti-citrullinated histone antibodies in vivo when engrafted in the Hu-RA/SCID chimeric model. (a) RA ELS+ synovial tissues RA015/11
and RA056/11 transplanted into SCID mice (arrow depict site of transplant) displayed persistent ELS after 4 weeks post-engraftment as shown in
representative pictures of sequential analysis of paraffin-embedded sections stained for H&E and for CD20 (B cells), CD3 (T cells) and CD138
(plasma cells) (B). (C) Serum from Hu-RA SCID mice engrafted with RA015/11 and RA056/11 synovia reproduced the reactivity towards NETs in
PMA-stimulated neutrophils. Representative pictures with NETs visualised by DAPI (blue) and the binding of human IgG in green are shown. (D)
Binding of the human IgG in Hu-RA SCID mice to citrullinated versus unmodified H2A and H2B histones by ELISA confirmed the immunoreactivity
observed with the recombinant monoclonal antibodies from the same patients. Results are shown as increased percentage in immunoreactivity in
citrullinated versus native H2A and H2B histones. (E) Stratification of synovial RA grafts based on citH2A and citH2B immunoreactivity versus
non-reactive demonstrated increased synovial expression of mRNA transcripts for CXCL13 and LTβ in anti-citH2A and citH2B reactive versus
non-reactive samples; *p<0.05.
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proteins (eg, LL37, HMGB1) promote the activation of profes-
sional antigen-presenting cells by facilitating antigen uptake,
interaction with endosomal Toll Like Receptor (TLR) and the
release of type-I Interferon (IFN) and other proinflammatory
cytokines as in the case of plasmacytoid DCs in SLE.42 43
Similarly, in autoimmune vasculitis, NETs are highly immuno-
genic and mediate the transfer of cytoplasmic neutrophil anti-
gens to myeloid dendritic cells, favouring the formation of
anti-neutrophil cytoplasmic antibodies.44
The clearance of NETs by macrophages is an immunologically
silent process. However, in an inflammatory environment, the
uptake of NETs can promote proinflammatory cytokines includ-
ing interleukin (IL)-1β, IL-6, and TNF-α,45 which are critical in
RA. Their processing followed by presentation of deiminated
antigens could elicit an adaptive immune response against citrul-
linated histones within GC in the RA joints, as also supported
by long-standing evidence that synovial RA macrophages
actively engulf neutrophil nuclear fragments.46 Although our
and previous work suggests that NETosis is an important source
of citrullinated proteins in the joints, several alternative/comple-
mentary mechanisms also likely contribute to the generation of
citrullinated antigens and ACPA in RA both within and outside
the joints. Environmental factors such as bacterial infection in
periodontal disease (ie, Porphyromonas gingivalis)47 48 and
smoking49 can lead to the formation of citrullinated antigens at
mucosal sites which, in susceptible individuals, can lead to the
production of ACPA prior to the clinical onset.4 Within the RA
joints, the activation of PADs by macrophages in the RA syno-
vium can bring to the citrullination of intracellular and extracel-
lular proteins such as vimentin and fibrin.11–13 Based on our
data, we propose that NETosis is an additional critical source of
citrullinated antigens within the synovium, whereby normally
sequestered citrullinated antigens within neutrophils, such as
core histones, can be hypercitrullinated, exposed and be tar-
geted by the immune system within the RA joints. Although a
formal mechanistic demonstration is still necessary, we propose
that the local release of citrullinated histones contribute to fuel
the antigen-driven generation of highly mutated B-cell clones
within synovial ELS resulting in the generation of high-affinity
ACPA displaying anti-NET reactivity (see online supplementary
figure S8).
A critical question which remains to be elucidated is whether
anti-NET antibodies generated in RA ELS are pathogenic and
contribute to chronic inflammation over and above ACPA gener-
ated in the peripheral compartment, as the pathogenic role of
ACPA remains controversial.50 51 Additionally, it is unclear
whether anti-NETs are generated in patients with early RAwhich
display a similar prevalence of ELS+ synovitis compared with
established RA.52 53 The combination of next-generation sequen-
cing followed by single cell cloning and recombinant antibody
production together with the availability of ultrasound-guided
synovial biopsies could help in clarifying this aspect.52 53
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